Milk-Derived EV Uptake in Intestinal Stem Cell Models

Milk-derived extracellular vesicles (MEV) are membrane-enclosed particles that transport proteins, nucleic acids, lipids, and other bioactive cargoes. Although previous work has examined their effects in intestinal cell lines and animal models, those systems do not fully reproduce the cellular composition, polarity, and barrier properties of intestinal epithelium. The reference study, Comprehensive investigation of milk-derived extracellular vesicles on intestinal stem cell–based models, addresses this gap with porcine intestinal stem cell (ISC)-derived models representing multiple gut regions and epithelial orientations.

Study Background and Research Question

The intestinal epithelium is continuously renewed by Lgr5-positive intestinal stem cells and their progeny. Enterocytes, goblet cells, enteroendocrine cells, and Paneth cells occupy specialized locations and perform distinct physiological functions. Immortalized epithelial cell lines are useful for controlled uptake experiments, but they generally lack this full lineage complexity and do not reproduce the three-dimensional organization of the intestinal barrier.

Organoids provide a more physiologically relevant alternative because stem cells self-organize into epithelial structures that retain features of the tissue from which they originated. However, organoid geometry creates an important experimental variable: in conventional basal-out organoids, the apical epithelial surface faces the enclosed lumen, whereas apical-out organoids expose the apical membrane to the surrounding medium. An organoid monolayer also provides direct access to the apical surface while enabling microscopy and barrier measurements.

The central question was therefore not simply whether porcine MEV enter intestinal cells. The study asked whether uptake depends on intestinal region and epithelial polarity, whether MEV influence ISC-related biology, and whether pharmacological inhibition of endocytosis can suppress vesicle internalization. These questions make the work relevant to intracellular trafficking research as well as to milk-bioactive and intestinal physiology studies.

Key Innovation from the Reference Study

The principal innovation is the integration of three complementary ISC-based formats: basal-out organoids, organoid monolayers, and apical-out organoids. According to the reference study, these models were generated from the duodenum, jejunum, ileum, and colon of suckling piglets. This design enables investigators to separate effects caused by tissue region from effects caused by membrane accessibility.

This polarity-aware approach is important because a negative uptake result in a conventional organoid may reflect limited access to the apical membrane rather than an absence of biological recognition. Conversely, uptake in an apical-out organoid or monolayer provides a more direct test of how luminally presented MEV interact with intestinal epithelial cells. The study therefore advances beyond a simple cell-associated fluorescence endpoint by incorporating model architecture into the interpretation of cellular entry.

A second innovation is the physiological validation of the organoid systems. The authors assessed epithelial cell composition, barrier properties, and fatty acid uptake before using the models to investigate MEV. This validation supports the interpretation that vesicle behavior was examined in an intestine-like context rather than in an undifferentiated epithelial culture.

Methods and Experimental Design Insights

Porcine milk was collected from healthy Large White pigs during the second week after parturition. The milk was pooled and processed under refrigerated conditions before crude MEV isolation by differential ultracentrifugation. This preparation strategy is widely used for enriching extracellular vesicles from complex fluids, although the resulting fraction should be interpreted as a biological mixture rather than as a chemically uniform particle population.

ISC-based cultures were established from four anatomical regions of the small intestine and colon. The investigators then compared the three structural formats to determine whether MEV could reach the epithelial surface. Functional characterization preceded uptake experiments, reducing the risk that differences in cell maturity or barrier formation would be mistaken for differences in vesicle internalization.

The experimental logic had three connected layers. First, the study established whether the cultures displayed key intestinal properties. Second, it assessed MEV uptake in models with different epithelial orientations. Third, it tested biological response and mechanism by measuring stemness- and differentiation-associated gene expression and examining the effect of endocytosis inhibitors. This layered design is valuable for membrane remodeling studies because it links physical access to the membrane with downstream cellular response.

Protocol Parameters

• Biological source: The study used intestinal tissue from suckling piglets and mature milk from three healthy Large White pigs; these literature-backed details are reported in the reference study.
• Milk handling: Milk was collected at approximately 10 to 14 days postpartum, pooled, and stored for less than 24 hours at 4°C before processing, according to the reported experimental design.
• MEV enrichment: Crude MEV were isolated using differential ultracentrifugation. Follow-on studies should characterize particle preparations and include matched preparation controls when attributing effects specifically to vesicles.
• Model formats: Basal-out organoids, organoid monolayers, and apical-out organoids were compared to resolve epithelial-polarity effects rather than relying on one organoid orientation.
• Physiological validation: IEC composition, epithelial barrier function, and fatty acid uptake were used to confirm that the ISC-derived models retained relevant intestinal properties.
• Mechanistic perturbation: MEV internalization was evaluated in the presence of endocytosis inhibitors. For future experiments, polarity, inhibitor exposure, vehicle treatment, and viability should be controlled in parallel so that reduced uptake is not attributed to nonspecific epithelial injury.
• Biological response: Stemness- and differentiation-related gene expression was examined, with particular attention to colon-derived ISC models. These transcriptional endpoints are best interpreted alongside functional readouts in subsequent studies.

Core Findings and Why They Matter

Uptake depends strongly on epithelial polarity

Porcine MEV were taken up by organoid monolayers and apical-out organoids, but not by basal-out organoids, through the accessible apical surface of intestinal epithelial cells. This result provides a clear methodological lesson: organoid orientation can determine whether a luminal particle appears to be internalized. A negative result in a basal-out configuration should not automatically be interpreted as evidence that the epithelial cell cannot recognize or transport MEV.

The finding also supports a model in which the apical membrane is a major interface for MEV interaction with intestinal epithelium. It does not, by itself, identify a specific receptor, vesicle class, or intracellular route. Instead, it establishes the spatial context in which more focused endocytosis experiments can be performed.

MEV influence ISC-associated transcriptional programs

The study reports that MEV promoted expression of genes associated with stemness and differentiation in colon-derived ISC models. This observation expands the significance of MEV beyond passive uptake or short-term cargo delivery. It suggests that vesicle exposure can influence regulatory programs linked to epithelial maintenance and lineage development.

Because the reported evidence is based on gene expression, the result should be viewed as evidence of molecular response rather than proof of altered tissue regeneration or improved barrier function. Nevertheless, it provides a useful starting point for testing whether MEV-associated transcriptional changes correspond to measurable changes in cell proliferation, lineage allocation, barrier integrity, or epithelial repair.

Endocytosis is involved, but the pathway is not fully resolved

Internalization was suppressed by endocytosis inhibitors, supporting an active uptake mechanism rather than nonspecific accumulation at the cell surface. This is a meaningful mechanistic advance because it connects MEV entry to cellular trafficking processes. It also makes the system suitable for evaluating an endocytosis research compound or a dynamin-directed perturbation in a physiologically relevant epithelial model.

However, inhibitor sensitivity is not equivalent to pathway identification. Unless the inhibitor panel is highly selective and supported by genetic or imaging evidence, suppression may reflect overlapping effects on membrane dynamics, cytoskeletal organization, or cell viability. The paper therefore narrows the mechanism to an endocytic process but does not establish that uptake is exclusively clathrin-dependent, caveolar, dynamin-dependent, or mediated by a single receptor.

Comparison with Existing Internal Articles

The internal article Milk-Derived Extracellular Vesicle Uptake in ISC Organoids provides a useful companion overview of the same research direction, particularly the relationship between porcine ISC organoids, MEV uptake, and stemness or differentiation. The reference study supplies the primary experimental backbone: it compares multiple organoid orientations, includes several intestinal regions, validates epithelial physiology, and tests the effect of endocytosis inhibitors.

The distinction matters for readers assessing evidence strength. A conceptual overview can help organize hypotheses about polarity and trafficking, whereas the reference paper provides the model construction and comparative observations needed to evaluate those hypotheses. Together, they support the use of ISC-derived cultures for cellular uptake mechanism studies without implying that every proposed trafficking route has already been demonstrated.

Limitations and Transferability

Several limitations define how far these findings can be generalized. First, the MEV preparation was obtained from milk by differential ultracentrifugation and described as crude. Such fractions can contain heterogeneous extracellular vesicle subpopulations and associated non-vesicular components. Consequently, biological effects cannot necessarily be assigned to one vesicle subtype or one cargo class.

Second, the models were porcine and derived from young animals. Porcine intestinal physiology is valuable for translational and agricultural research, but species, developmental stage, diet, and regional differences may influence epithelial polarity, receptor abundance, and uptake capacity. Human ISC-derived organoids and primary intestinal tissue would be needed to assess direct clinical or human nutritional relevance.

Third, the reported inhibitor experiments demonstrate pharmacological sensitivity of uptake but do not establish molecular specificity. Genetic depletion, rescue experiments, pathway-resolved imaging, and measurements of cell viability would strengthen causal interpretation. Likewise, transcriptional changes in colon-derived ISC should be complemented by functional assays before concluding that MEV alter long-term epithelial regeneration.

Why this cross-domain matters, maturity, and limitations

Using this MEV study to guide broader membrane-trafficking or endocytosis experiments is a methodological bridge, not a claim that the paper validated every available inhibitor. Its maturity is therefore intermediate: the polarity-dependent uptake phenotype is a strong platform-level observation, while the identity of the endocytic machinery remains open. Researchers transferring the workflow to intracellular trafficking research should preserve the study’s strongest features—regional comparison, epithelial orientation, physiological validation, and matched controls—while treating pharmacological pathway assignment as a follow-up question.

Research Support Resources

For follow-up assays that test whether MEV uptake depends on dynamin GTPase activity, researchers can use MitMAB (N,N,N-trimethyltetradecan-1-aminium bromide; SKU B7620), a dynamin GTPase activity inhibitor intended for research use. In ISC organoids or monolayers, it can support a hypothesis-driven comparison of apical uptake, provided that vehicle, viability, polarity, and inhibitor-specific controls are included. This makes it a potential cellular uptake mechanism inhibitor for extending the reference study, rather than a substitute for genetic validation or direct pathway characterization.